UBS AM’s Compugen CGEN Stock Holding History

UBS AM’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-62,030	Closed	-$200K	–	2703
2022 Q1	$200K	Hold	62,030	–	–	﹤0.01%	2681
2021 Q4	$267K	Buy	62,030 +3,380	+6%	+$18.3K	﹤0.01%	2706
2021 Q3	$350K	Hold	58,650	–	–	﹤0.01%	2592
2021 Q2	$486K	Sell	58,650 -14,500	-20%	-$118K	﹤0.01%	2548
2021 Q1	$628K	Hold	73,150	–	–	﹤0.01%	2303
2020 Q4	$886K	Sell	73,150 -3,300	-4%	-$45.5K	﹤0.01%	2048
2020 Q3	$1.24M	Buy	76,450 +18,800	+33%	+$308K	﹤0.01%	1755
2020 Q2	$866K	Buy	+57,650	New	+$778K	﹤0.01%	1867

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

UBS AM's CGEN Position: Q2 2022 in Review

UBS AM sold out of Compugen (CGEN) in Q2 2022, closing a stake of 62,030 shares — an estimated $200K sold.

UBS AM first reported a position in CGEN in Q2 2020 and held it in 8 quarters. The position peaked at $1.24M in Q3 2020. 89 funds tracked by Wall St. Rank hold CGEN as of Q2 2022.

UBS AM reported no remaining Compugen position as of Q2 2022 after selling out during the quarter.
UBS AM sold 62,030 Compugen shares in Q2 2022, an estimated $200K.
UBS AM first reported a position in Compugen in Q2 2020 and held it in 8 quarters.
UBS AM's Compugen position peaked at $1.24M in Q3 2020.
89 funds tracked by Wall St. Rank held Compugen as of Q2 2022.

Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.